Clinical Trial

Efficacy and Safety of DWP14012 for Long-Term Maintenance Therapy in Patients With Healed Erosive Esophagitis

Not Yet Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
A Multi-center, Double-blind, Randomized, Active-controlled, Parallel-group, Phase III Clinical Trial and Open-label Extension Study to Evaluate the Efficacy and Safety of DWP14012 for Maintenance Therapy in Patients with Healed Erosive Esophagitis
Trial Details
NCT Number NCT07746518
Lead Sponsor Daewoong Pharmaceutical Co. LTD.
Conditions Healed Erosive Esophagitis
Enrollment 420 participants
Start Date 2026-09
Primary Completion 2029-08 (estimated)
Study Completion 2030-03 (estimated)
Updated on ClinicalTrials.gov 2026-08-13